Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ana Martinez & Carmen Gil. (2014) cAMP-specific phosphodiesterase inhibitors: promising drugs for inflammatory and neurological diseases. Expert Opinion on Therapeutic Patents 24:12, pages 1311-1321.
Read now
Read now
Maliheh Safavi, Maryam Baeeri & Mohammad Abdollahi. (2013) New methods for the discovery and synthesis of PDE7 inhibitors as new drugs for neurological and inflammatory disorders. Expert Opinion on Drug Discovery 8:6, pages 733-751.
Read now
Read now
Mercedes González & Hugo Cerecetto. (2012) Quinoxaline derivatives: a patent review (2006 – present). Expert Opinion on Therapeutic Patents 22:11, pages 1289-1302.
Read now
Read now
Articles from other publishers (36)
Heena Khan, Chanchal Tiwari, Amarjot Kaur Grewal, Thakur Gurjeet Singh, Simran Chauhan & Gaber El-Saber Batiha. (2022) Pharmacological modulation of phosphodiesterase-7 as a novel strategy for neurodegenerative disorders. Inflammopharmacology 30:6, pages 2051-2061.
Crossref
Crossref
Haobai Liu, Quan Wang, Yue Huang, Jinhui Deng, Xi Xie, Jiaqi Zhu, Yijun Yuan, Yue-Ming He, Yi-You Huang, Hai-Bin Luo & Xixin He. (2022) Discovery of novel PDE4 inhibitors targeting the M-pocket from natural mangostanin with improved safety for the treatment of Inflammatory Bowel Diseases. European Journal of Medicinal Chemistry 242, pages 114631.
Crossref
Crossref
Monika Dąbrowska, Małgorzata Starek, Grażyna Chłoń-Rzepa, Agnieszka Zagórska, Łukasz Komsta, Agnieszka Jankowska, Marietta Ślusarczyk & Maciej Pawłowski. (2021) Estimation of the lipophilicity of purine-2,6-dione-based TRPA1 antagonists and PDE4/7 inhibitors with analgesic activity. Bioorganic & Medicinal Chemistry Letters 49, pages 128318.
Crossref
Crossref
Kamilia M. Amin, Gehan H. Hegazy, Riham F. George, Nahla R. Ibrahim & Nada M. Mohamed. (2021)
Design, synthesis, and pharmacological characterization of some 2‐substituted‐3‐phenyl‐quinazolin‐4(3
H
)‐one derivatives as phosphodiesterase inhibitors
. Archiv der Pharmazie 354:9, pages 2100051.
Crossref
Crossref
Agnieszka Jankowska, Maciej Pawłowski & Grażyna Chłoń-Rzepa. (2021) Diabetic Theory in Anti-Alzheimer’s Drug Research and Development. Part 2: Therapeutic Potential of cAMP-Specific Phosphodiesterase Inhibitors. Current Medicinal Chemistry 28:18, pages 3535-3553.
Crossref
Crossref
Susann Schröder, Matthias Scheunemann, Barbara Wenzel & Peter Brust. (2021) Challenges on Cyclic Nucleotide Phosphodiesterases Imaging with Positron Emission Tomography: Novel Radioligands and (Pre-)Clinical Insights since 2016. International Journal of Molecular Sciences 22:8, pages 3832.
Crossref
Crossref
Veronika Ručilová, Artur Świerczek, David Vanda, Petr Funk, Barbora Lemrová, Alicja Gawalska, Adam Bucki, Barbara Nowak, Monika Zadrożna, Krzysztof Pociecha, Miroslav Soural, Elżbieta Wyska, Maciej Pawłowski, Grażyna Chłoń-Rzepa & Paweł Zajdel. (2021) New imidazopyridines with phosphodiesterase 4 and 7 inhibitory activity and their efficacy in animal models of inflammatory and autoimmune diseases. European Journal of Medicinal Chemistry 209, pages 112854.
Crossref
Crossref
Ajmer Singh Grewal, Neelam Sharma, Sukhbir Singh & Sandeep Arora. (2019) In Silico Designing of Novel Thiazolidine-2-one Derivatives as Dual PDE4/7 Inhibitors for Inflammatory Disorders. Journal of Pharmaceutical Technology, Research and Management 5:2, pages 149-162.
Crossref
Crossref
Himanshu Sharma, Viney Lather, Ajmer Singh Grewal & Deepti Pandita. (2019) Synthesis, Anti-inflammatory Activity and Docking Studies of Some Newer 1,3-Thiazolidine-2,4-dione Derivatives as Dual Inhibitors of PDE4 and PDE7. Current Computer-Aided Drug Design 15:3, pages 225-234.
Crossref
Crossref
Nazanin Namazi Sarvestani, Saeedeh Saberi Firouzi, Reza Falak, Mohammad Yahya Karimi, Mohammad Davoodzadeh Gholami, Akram Rangbar & Asieh Hosseini. (2018) Phosphodiesterase 4 and 7 inhibitors produce protective effects against high glucose-induced neurotoxicity in PC12 cells via modulation of the oxidative stress, apoptosis and inflammation pathways. Metabolic Brain Disease 33:4, pages 1293-1306.
Crossref
Crossref
Yinuo Wu, Zhe Li, Yi-You Huang, Deyan Wu & Hai-Bin Luo. (2018) Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer’s Disease. Journal of Medicinal Chemistry 61:13, pages 5467-5483.
Crossref
Crossref
Vinny Lather, Ajmer Singh Grewal, Pardeep Kumar & Jagdeep Singh Dua. (2017) Synthesis, Docking and Anti-inflammatory Activity of Some Newer Triazole Derivatives as Potential PDE7 Inhibitors. Journal of Medicinal Chemistry and Toxicology 2:2, pages 55-61.
Crossref
Crossref
R. Martín-Álvarez, N. Paúl-Fernández, V. Palomo, C. Gil, A. Martínez & G. Mengod. (2017) A preliminary investigation of phoshodiesterase 7 inhibitor VP3.15 as therapeutic agent for the treatment of experimental autoimmune encephalomyelitis mice. Journal of Chemical Neuroanatomy 80, pages 27-36.
Crossref
Crossref
J. Mercier, L. Provins & J. Hannestad. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
20
64
.
Susann Schröder, Barbara Wenzel, Winnie Deuther-Conrad, Matthias Scheunemann & Peter Brust. (2016) Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012. Molecules 21:5, pages 650.
Crossref
Crossref
Tarana Umar & Nasimul Hoda. (2015) Selective inhibitors of phosphodiesterases: therapeutic promise for neurodegenerative disorders. MedChemComm 6:12, pages 2063-2080.
Crossref
Crossref
David Thomae, Stijn Servaes, Naiara Vazquez, Leonie wyffels, Stefanie Dedeurwaerdere, Pieter Van der Veken, Jurgen Joossens, Koen Augustyns, Sigrid Stroobants & Steven Staelens. (2015) Synthesis and preclinical evaluation of an 18 F labeled PDE7 inhibitor for PET neuroimaging. Nuclear Medicine and Biology 42:12, pages 975-981.
Crossref
Crossref
Ana M. García, José Brea, Jose A. Morales-GarcíaDaniel I. Perez, Alejandro González, Sandra Alonso-GilIrene Gracia-Rubio, Clara Ros-Simó, Santiago Conde, María Isabel Cadavid, María Isabel Loza, Ana Perez-CastilloOlga Valverde, Ana Martinez & Carmen Gil. (2014) Modulation of cAMP-Specific PDE without Emetogenic Activity: New Sulfide-Like PDE7 Inhibitors. Journal of Medicinal Chemistry 57:20, pages 8590-8607.
Crossref
Crossref
Frank S. Menniti, Niels Plath, Niels Svenstrup & Christopher J. Schmidt. 2014. Cyclic-Nucleotide Phosphodiesterases In The Central Nervous System. Cyclic-Nucleotide Phosphodiesterases In The Central Nervous System
77
114
.
Nigel A. Swain & Rainer Gewald. 2014. Phosphodiesterases and Their Inhibitors. Phosphodiesterases and Their Inhibitors
165
190
.
Ana I. Sánchez, Ricardo Meneses, José M. Mínguez, Araceli Núñez, Rafael R. Castillo, Fabiana Filace, Carolina Burgos, Juan J. Vaquero, Julio Álvarez-Builla, Alvaro Cortés-Cabrera, Federico Gago, Emma Terricabras & Víctor Segarra. (2014) Microwave-assisted synthesis of potent PDE7 inhibitors containing a thienopyrimidin-4-amine scaffold. Org. Biomol. Chem. 12:24, pages 4233-4242.
Crossref
Crossref
Rocio Perez-Gonzalez, Consuelo Pascual, Desiree Antequera, Marta Bolos, Miriam Redondo, Daniel I. Perez, Virginia Pérez-Grijalba, Agnieszka Krzyzanowska, Manuel Sarasa, Carmen Gil, Isidro Ferrer, Ana Martinez & Eva Carro. (2013) Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease. Neurobiology of Aging 34:9, pages 2133-2145.
Crossref
Crossref
Ana Martinez & Carmen Gil. 2013. Emerging Drugs and Targets for Parkinson’s Disease. Emerging Drugs and Targets for Parkinson’s Disease
294
307
.
Ana I. Sánchez, Valentín Martínez-Barrasa, Carolina Burgos, Juan J. Vaquero, Julio Alvarez-Builla, Emma Terricabras & Víctor Segarra. (2013) Synthesis and evaluation of quinazoline derivatives as phosphodiesterase 7 inhibitors. Bioorganic & Medicinal Chemistry 21:8, pages 2370-2378.
Crossref
Crossref
Ma José Jerez, Miguel Jerez, Coral González-García, Sara Ballester & Ana Castro. (2013) Combined use of pharmacophoric models together with drug metabolism and genotoxicity “in silico” studies in the hit finding process. Journal of Computer-Aided Molecular Design 27:1, pages 79-90.
Crossref
Crossref
Miriam Redondo, Valle Palomo, José Brea, Daniel I. Pérez, Rocío Martín-Álvarez, Concepción Pérez, Nuria Paúl-Fernández, Santiago Conde, María Isabel Cadavid, María Isabel Loza, Guadalupe Mengod, Ana Martínez, Carmen Gil & Nuria E. Campillo. (2012)
Identification
in Silico
and Experimental Validation of Novel Phosphodiesterase 7 Inhibitors with Efficacy in Experimental Autoimmune Encephalomyelitis Mice
. ACS Chemical Neuroscience 3:10, pages 793-803.
Crossref
Crossref
Abhisek Banerjee, Sandip Patil, Mahesh Y. Pawar, Srinivas Gullapalli, Praveen K. Gupta, Maulik N. Gandhi, Deepak K. Bhateja, Malini Bajpai, Ramachandra Rao Sangana, Girish S. Gudi, Neelima Khairatkar-Joshi & Laxmikant A. Gharat. (2012) Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson’s disease model. Bioorganic & Medicinal Chemistry Letters 22:19, pages 6286-6291.
Crossref
Crossref
Abhisek Banerjee, Pravin S. Yadav, Malini Bajpai, Ramachandra Rao Sangana, Srinivas Gullapalli, Girish S. Gudi & Laxmikant A. Gharat. (2012) Isothiazole and isoxazole fused pyrimidones as PDE7 inhibitors: SAR and pharmacokinetic evaluation. Bioorganic & Medicinal Chemistry Letters 22:9, pages 3223-3228.
Crossref
Crossref
Miriam Redondo, José Brea, Daniel I. Perez, Ignacio Soteras, Cristina Val, Concepción Perez, Jose A. Morales-García, Sandra Alonso-Gil, Nuria Paul-Fernandez, Rocío Martin-Alvarez, María Isabel Cadavid, María Isabel Loza, Ana Perez-Castillo, Guadalupe Mengod, Nuria E. Campillo, Ana Martinez & Carmen Gil. (2012) Effect of Phosphodiesterase 7 (PDE7) Inhibitors in Experimental Autoimmune Encephalomyelitis Mice. Discovery of a New Chemically Diverse Family of Compounds. Journal of Medicinal Chemistry 55:7, pages 3274-3284.
Crossref
Crossref
Daniel I. Pérez, Marco Pistolozzi, Valle Palomo, Miriam Redondo, Cecilia Fortugno, Carmen Gil, Guy Felix, Ana Martinez & Carlo Bertucci. (2012) 5-Imino-1,2-4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3β (GSK-3β) and phosphodiesterase 7 (PDE7) inhibitors: Determination of blood–brain barrier penetration and binding to human serum albumin. European Journal of Pharmaceutical Sciences 45:5, pages 677-684.
Crossref
Crossref
Miriam Redondo, Juan G. Zarruk, Placido Ceballos, Daniel I. Pérez, Concepción Pérez, Ana Perez-Castillo, María A. Moro, José Brea, Cristina Val, María I. Cadavid, María I. Loza, Nuria E. Campillo, Ana Martínez & Carmen Gil. (2012) Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model. European Journal of Medicinal Chemistry 47, pages 175-185.
Crossref
Crossref
Rainer Gewald, Carla Rueger, Christian Grunwald, Ute Egerland & Norbert Hoefgen. (2011) Synthesis and structure–activity relationship studies of dihydronaphthyridinediones as a novel structural class of potent and selective PDE7 inhibitors. Bioorganic & Medicinal Chemistry Letters 21:22, pages 6652-6656.
Crossref
Crossref
Irene Paterniti, Emanuela Mazzon, Carmen Gil, Daniela Impellizzeri, Valle Palomo, Myriam Redondo, Daniel I. Perez, Emanuela Esposito, Ana Martinez & Salvatore Cuzzocrea. (2011) PDE 7 Inhibitors: New Potential Drugs for the Therapy of Spinal Cord Injury. PLoS ONE 6:1, pages e15937.
Crossref
Crossref
Mark A. Giembycz & Robert Newton. 2011. Phosphodiesterases as Drug Targets. Phosphodiesterases as Drug Targets
415
446
.
Kelly R. Bales, Niels Plath, Niels Svenstrup & Frank S. Menniti. 2010. Neurodegenerative Diseases. Neurodegenerative Diseases
57
90
.
Tania Castaño, Huanchen Wang, Nuria E. Campillo, Sara Ballester, Coral González-García, Javier Hernández, Concepción Pérez, Jimena Cuenca, Ana Pérez-Castillo, Ana Martínez, Oscar Huertas, José Luis Gelpí, F. Javier Luque, Hengming Ke & Carmen Gil. (2009) Synthesis, Structural Analysis, and Biological Evaluation of Thioxoquinazoline Derivatives as Phosphodiesterase 7 Inhibitors. ChemMedChem 4:5, pages 866-876.
Crossref
Crossref